Newsletter
Every new paper in this field, in your inbox.
Examining outcomes in metastatic colorectal cancer treatment, researchers conducted a review, analyzing six selected studies. Comparing surgical interventions on the liver and peritoneum, cytoreductive surgery with heated intraperitoneal chemotherapy showed comparable safety and survival outcomes to hepatectomy. This suggests a need for early integration of…
In a pilot trial, colorectal cancer patients undergoing elective surgery were randomized to receive standard consent (CT images) or virtual reality (VR) consent (CT images and immersive VR models). While not statistically significant, VR showed a trend toward improved patient-reported understanding, with most patients preferring…
Contrary to the conventional recommendation, researchers analyzed SEER data (2004-2015) for stage III rectal mucinous adenocarcinoma (RMC) patients. RMC, distinct in T and N stage at diagnosis, emerged as an independent poor prognostic factor for overall and cancer-specific survival. Notably, adjuvant radiotherapy failed to confer…
Examining 1404 Crohn's disease patients post-ileocecal resection, researchers identified high-risk factors for surgical recurrence (multiple surgeries, active smoking, penetrating or perianal disease). Biologic prophylaxis post-surgery lowered surgical recurrence in high-risk patients. Additionally, prophylaxis reduced endoscopic recurrence regardless of risk, suggesting its potential benefits across risk…
The 8th ECCO scientific workshop addressed postoperative recurrence (POR) in Crohn's disease after ileocolonic resection. Despite modern therapies, POR remains a challenge, impacting patients' lives. The workshop extensively reviewed data on preventive and treatment strategies, including medications, endoscopic procedures, and surgery. Synthesizing available knowledge, the…
Analyzing 634 nonmetastatic pT4a colorectal cancer patients (2015–2021), researchers compared minimally invasive surgery (MIS) and laparotomy outcomes. MIS exhibited lower blood loss, quicker recovery parameters, and a 3.5% conversion rate. After 5 years, MIS showed comparable overall survival (72.7%) and disease-free survival (72.2%) to laparotomy.…
In a nonrandomized cohort pilot study, researchers explored the feasibility and safety of single-incision robotic-assisted surgery (SIRAS) using the Shurui Endoscopic Surgical Robotic System (SR-ENS-600). Seven patients underwent successful SIRAS for colorectal malignancy. The SR-ENS-600 platform exhibited preferable maneuverability/stability in confined fields. Although one case…
Examining 3,189 patients with 1- to 2-cm neuroendocrine tumors of the appendix, researchers found that while the appendectomy rate increased over the years, it wasn't linked to improved survival compared to right hemicolectomy. Grade 2 and 3 tumors were associated with a lower likelihood of…
In a study spanning January 2022 to January 2023, researchers explored the safety and viability of a pioneering stent-assisted ileal bypass for individuals undergoing sphincter-preserving surgery for rectal cancer. With 11 successful cases, the innovative approach, involving a biofragmentable ileal stent and diversion tube, proved…
Investigating the potential cardiovascular benefits of postoperative stellate ganglion block (SGB) after laparoscopic colorectal cancer surgery, this randomized trial aims to enroll 950 patients with at least one risk factor for myocardial injury after non-cardiac surgery. Assessing outcomes such as myocardial injury incidence, pain levels,…
